Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03894930 · ClinicalTrials.gov registry record · NA
Metta Meditation Training on Prosocial Behavior
A NA study, sponsored by Georgetown University.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT03894930: Completed NA study, sponsored by Georgetown University.
NCT03894930 is a NA study that has completed, run by Georgetown University. The registered enrollment target is 67 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03894930, a NA study, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
The purpose of the study is to look at the impact of a metta meditation training on prosocial behavior and socio-affective brain responses. The training involves an 8-week, online administration of guided metta meditation practices aimed at generating feelings of kindness and compassion for other people. The study examines how participants respond to thinking about familiar others and strangers using behavioral and brain-imaging measures. This study will be important for understanding how people develop the capacity to be prosocial towards other individuals, which is a key component of adaptive social behavior.
Primary Outcome
During functional magnetic resonance imaging (fMRI) scanning, participants will complete a social discounting task. Participants will choose whether to forgo various amounts of money to give to another person. Behavioral and brain responses will be analyzed to assess social discounting in each participant.
Interventions
- BEHAVIORAL Metta meditation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2018-09-25 |
| Est. Completion | 2021-05-14 |
| Phase | NA |
What the finished NCT03894930 record still lists
NCT03894930 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Metta meditation is the first listed.
NCT03894930 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03894930 about?
NCT03894930 is a clinical study titled "Metta Meditation Training on Prosocial Behavior". The purpose of the study is to look at the impact of a metta meditation training on prosocial behavior and socio-affective brain responses. The training involves an 8-week, online administration of guided metta meditation practices aimed at generating feelings of kindness and compassion for other pe...
What is the current status of trial NCT03894930?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2018-09-25. Estimated completion is 2021-05-14.
What interventions are being tested in trial NCT03894930?
The interventions under investigation include: Metta meditation (BEHAVIORAL).
Who is sponsoring clinical trial NCT03894930?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03894930's enrollment target sits among peer trials
67 1139th of 2000 higher than 862 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI